We serve Chemical Name:3-iodo-4-methylbenzamide CAS:269411-70-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-iodo-4-methylbenzamide
CAS.NO:269411-70-3
Synonyms:3-iodo-4-methyl-benzoic acid amide;Benzamide,3-iodo-4-methyl;3-Jod-4-methyl-benzoesaeure-amid;3-iodo-4-methyl benzamide;3-Jod-4-methyl-benzamid
Molecular Formula:C8H8INO
Molecular Weight:261.06000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.09000
Exact Mass:260.96500
LogP:2.39880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-iodo-4-methyl-benzoic acid amide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Jod-4-methyl-benzamid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Jod-4-methyl-benzoesaeure-amid Use and application,3-Jod-4-methyl-benzoesaeure-amid technical grade,usp/ep/jp grade.
Related News: The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion. methyl (2S)-2,6-bis[(2-hexyl-3-oxodecanoyl)amino]hexanoate manufacturers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 1-[3-(furan-2-yl)-acryloyl]-2-cyanoaziridine suppliers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 (5S,6R,7R)-5-(benzo[d][1,3]dioxol-5-yl)-7-(2-((R)-3-(dimethylamino)-2-methyl-3-oxopropyl)-4-methoxyphenyl)-2-(isopropylamino)-6,7-dihydro-5H-cyclopenta[b]pyridine-6-carboxylic acid vendor & factory The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion.,EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML).
